STAA STAAR SURGICAL CO

8-K Current Report

Filed: March 3, 2026

Health Care

Ophthalmic Goods

STAAR SURGICAL CO (STAA) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year FY2025 results reported (fiscal year ended January 2, 2026)
• Full financials in Exhibit 99.1 — press release is the primary source for revenue, margins, and guidance

+1 more insights

Item 7.01 · Regulation FD Disclosure

• Earnings call scheduled March 3, 2026 at 5:30 p.m. ET covering Q4 and full-year results ended January 2, 2026
• Dual Interim Co-CEOs presenting — COO and CFO sharing top role signals ongoing leadership transition

+1 more insights

Get deeper insights on STAAR SURGICAL CO

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.